Replimune Group, Inc. Share Price
NASDAQ: REPL | Small CapReplimune Group, Inc. Stock Performance
Replimune Group, Inc. Share Price Today
As of 19 September 2026, Replimune Group, Inc.'s share price is $13.04. The stock opened at $12.93, compared to its previous close of $12.85. During today's trading session, Replimune Group, Inc.'s share price traded between $12.76 and $13.19, with an average price of $12.97. Over the past 52 weeks, the stock has recorded a high of $16.30 and a low of $1.50. In terms of performance, Replimune Group, Inc.'s share price has risen by 70.75% over the last six months and is up 212.83% on a year-on-year basis.
Replimune Group, Inc. Share Price Chart
About Replimune Group, Inc.
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Replimune Group, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $15.37 | $13.05 | -16.35% |
Aug 2026 | $11.27 | $15.60 | +39.22% |
Jul 2026 | $11.45 | $11.21 | +1.31% |
Jun 2026 | $8.95 | $11.06 | +27.13% |
May 2026 | $2.52 | $8.70 | +240.51% |
Apr 2026 | $7.78 | $2.56 | -66.56% |
Mar 2026 | $7.55 | $7.64 | -0.20% |
Feb 2026 | $6.93 | $7.66 | +9.05% |
Jan 2026 | $9.71 | $7.02 | -27.70% |
Dec 2025 | $10.00 | $9.71 | -3.00% |
Nov 2025 | $9.40 | $10.01 | +2.98% |
Oct 2025 | $4.17 | $9.72 | +133.09% |